 |
인쇄하기
취소
|
‘Xalost’ ophthalmic agent goes to 17 European countries
Xalost (latanoprost) eye drop, a glaucoma drug, will be exported to 17 European countries, Taejoon Pharma announced on Monday.
Taejoon has recently received the marketing authorization for Xalost in Switzerland and Bulgaria following the approval from the German health ministry on April 2009.
Xalost got the GE certification from the Korea Health Industry Development Institute and was also...
Taejoon has recently received the marketing authorization for Xalost in Switzerland and Bulgaria following the approval from the German health ministry on April 2009.
Xalost got the GE certification from the Korea Health Industry Development Institute and was also...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.